Skip to content

Study of the restrictive strabismus in thyroid-associated ophthalmopathy

Study of the restrictive strabismus in thyroid-associated ophthalmopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117065
Enrollment
Unknown
Registered
2026-01-19
Start date
2026-01-26
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restrictive strabismus in thyroid-associated ophthalmopathy

Interventions

The esotropia group:None
The upper strabismus group:None
The lower strabismus group:None

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients at our hospital with a clear diagnosis of thyroid-associated ophthalmopathy (TAO) accompanied by restrictive strabismus, requiring surgical correction to improve visual function, appearance, and quality of life 2. Ocular symptoms stable for more than 6 months 3. Patients with exophthalmos undergo orbital decompression first, followed by strabismus surgery after stabilization

Exclusion criteria

Exclusion criteria: 1.Combined with other ocular diseases such as ocular inflammation, glaucoma, etc

Design outcomes

Primary

MeasureTime frame
Strabismus degree (prism cover test), eyelid retraction status;Amount of extraocular muscle recession, immediate postoperative strabismus degree during surgery, and intraoperative complications;Eye status, strabismus degree, and incidence of postoperative complications at postoperative day 1, week 1, month 1, month 3, 6 months, and 1 year;

Countries

China

Contacts

Public ContactZhao Liang

Tianjin Medical University Eye Hospital

576310500@qq.com+86 22 86428809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026